PubRank
Search
About
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.
Clinical Trial ID NCT00334334
PubWeight™ 10.41
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT00334334
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
Pediatr Infect Dis J
2009
1.80
2
Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
Pediatr Infect Dis J
2009
1.13
3
Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
Pediatr Infect Dis J
2009
1.09
4
Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Pediatr Infect Dis J
2009
1.05
5
Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease.
Vaccine
2009
0.99
6
Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines.
Clin Vaccine Immunol
2010
0.98
7
Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption.
Clin Vaccine Immunol
2011
0.93
8
Prevention of otitis media: now a reality?
Vaccine
2009
0.92
9
Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience.
Adv Prev Med
2011
0.88
10
Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines.
Clin Vaccine Immunol
2016
0.75
Next 100